Eyenovia reported a net loss of $2.2 million, or $0.84 per share, in the fourth quarter of 2017 compared with a net loss of $1.2 million, or $0.51 per share, in the fourth quarter of 2016, according to a press release.
Research and development costs increased from $1 million in 2016’s final quarter to $1.7 million in the same time period of 2017, while general and administrative expenses rose from $0.2 million to $0.5 million.
For the full year, the company posted a net loss of $5.1 million, or $2.19 (Read more...)
Uncategorized